After hours
You're reading the free version. Trader adds the live tape and alerts. Start tracking

1 trade

Disclosure transactions for Inmed Pharmaceuticals Inc.
Reporting person Filed Transaction Transaction value Source Actions
Adar1 Capital Management, Llc 10% owner Nov 9, 2026 4-day lag Buy Nov 5, 2026 $34.57K Filed shares x price SEC Form 4 View filing
Adar1 Capital Management, Llc 10% owner
Buy
Calculated transaction value
$34.57K 2,640 shares @ $13.1
Traded
Nov 5, 2026
Filed
Nov 9, 2026